Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
28.32%
40%
—
—
Every year
—
5 Years
Score—
Net Growth28.32%
Net Trend40%
Net Income Consistency—
Rev Growth—
Rev TrendEvery year
Revenue Consistency—
InMed Pharmaceuticals Inc fundamental performance
Across InMed Pharmaceuticals Inc's full reported history, from 2021 to 2025, revenue grew from $ 0.00 to $ 4M and net income went from -$ 12M to -$ 8M. Revenue increased in 100% of the years measured; net income in 40%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.44 | — |
1 Year2025-08-12 | $ 2.21 | -34.84% |
5 Years2021-08-12 | $ 1.24K | -99.88% |
10 Years2016-08-12 | $ 1.04K | -99.86% |
All Time2020-11-12 | $ 1.63K | -99.91% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2020-11-12 |
|---|---|---|---|---|---|
| Price | $ 1.44 | $ 2.21 | $ 1.24K | $ 1.04K | $ 1.63K |
| Return | — | -34.84% | -99.88% | -99.86% | -99.91% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 5M | -$ 9M | $ 9M |
| 2025 | $ 4M | -$ 8M | $ 15M |
| 2024 | $ 4M | -$ 7M | $ 8M |
| 2023 | $ 4M | -$ 7M | $ 11M |
| 2022 | $ 1M | -$ 18M | $ 8M |
| 2021 | $ 0.00 | -$ 12M | $ 9M |
Explore beyond INM
You're looking at InMed Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
